Bioequivalency Study of Torsemide Tablets Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Edema
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 28
- Registration Number
- NCT00602303
- Locations
- ๐บ๐ธ
Bio-Kinetic Clinical Applications, Inc., Springfield, Missouri, United States
Bioequivalency Study of Sertraline Under Fed Conditions
Not Applicable
Completed
- Conditions
- Depression
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 43
- Registration Number
- NCT00601588
- Locations
- ๐จ๐ฆ
Anapharm Inc., Sainte-Fly, Quebec, Canada
Bioequivalency Study of Zolpidem Tartrate Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Insomnia
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 30
- Registration Number
- NCT00601666
- Locations
- ๐บ๐ธ
PRACS Institute, Ltd., Fargo, North Dakota, United States
Bioequivalence Study of 6-Mercaptopurine Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Acute Lymphoblastic Leukemia
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 54
- Registration Number
- NCT00602134
- Locations
- ๐บ๐ธ
MDS Pharma Services, Phoenix, Arizona, United States
Bioequivalency Study of Terbinafine Tablets Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Onychomycosis
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 30
- Registration Number
- NCT00602342
- Locations
- ๐บ๐ธ
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
Bioequivalency Study of 5 mg Pilocarpine Tablets Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Dry Mouth
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 28
- Registration Number
- NCT00601874
- Locations
- ๐บ๐ธ
CEDRA Clinical Research, LLC, Austin, Texas, United States
Bioequivalency Study of Zidovudine Under Fed Conditions
Not Applicable
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 52
- Registration Number
- NCT00601562
- Locations
- ๐บ๐ธ
CEDRA Clinical Research, LLC, Austin, Texas, United States
Bioequivalency Study of Amlodipine Tablets Under Fed Conditions
Not Applicable
Completed
- Conditions
- Chronic Stable AnginaVasospastic AnginaHypertension
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 40
- Registration Number
- NCT00601302
- Locations
- ๐บ๐ธ
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
Bioequivalency Study of 300 mg Lithium Carbonate Under Fed Conditions
Not Applicable
Completed
- Conditions
- Bipolar Disorder
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 30
- Registration Number
- NCT00602394
- Locations
- ๐บ๐ธ
Novum Pharmaceutical Research Services, 11248 Wilcrest Green, , Houston77042, Houston, Texas, United States